Literature DB >> 27144620

The Intestinal Microenvironment and Functional Gastrointestinal Disorders.

Giovanni Barbara1, Christine Feinle-Bisset2, Uday C Ghoshal3, Eamonn M Quigley4, Javier Santos5, Steve Vanner6, Nathalie Vergnolle7, Erwin G Zoetendal8.   

Abstract

For decades, interactions between the enteric neuromuscular apparatus and the central nervous system have served as the primary focus of pathophysiological research in the functional gastrointestinal disorders. The accumulation of patient reports, as well as clinical observations, has belatedly led to an interest in the role of various luminal factors and their interactions with each other and the host in functional gastrointestinal disorders. Most prominent among these factors has been the role of food. As a consequence, while not always evidence-based, dietary interventions are enjoying a renaissance in irritable bowel syndrome management. Not surprisingly, given its exploration in many disease states, the gut microbiota has also been studied in functional gastrointestinal disorders; data remain inconclusive. Likewise, there is also a considerable body of experimental and some clinical data to link functional gastrointestinal disorders pathogenesis to disturbances in epithelial barrier integrity, abnormal entero-endocrine signaling and immune activation. These data provide growing evidence supporting the existence of micro-organic changes, particularly in subgroups of patients with functional dyspepsia and IBS. However, their exact role in the complex pathophysiology and symptom generation of functional gastrointestinal disorders needs to be further studied and elucidated particularly with longitudinal and interventional studies.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bile acids; food; functional dyspepsia; immune system; irritable bowel syndrome; microbiota; serotonin

Year:  2016        PMID: 27144620     DOI: 10.1053/j.gastro.2016.02.028

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  59 in total

Review 1.  New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.

Authors:  Emanuele Sinagra; Gaetano Cristian Morreale; Ghazaleh Mohammadian; Giorgio Fusco; Valentina Guarnotta; Giovanni Tomasello; Francesco Cappello; Francesca Rossi; Georgios Amvrosiadis; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

2.  A randomized double-blind placebo-controlled trial showing rifaximin to improve constipation by reducing methane production and accelerating colon transit: A pilot study.

Authors:  Uday C Ghoshal; Deepakshi Srivastava; Asha Misra
Journal:  Indian J Gastroenterol       Date:  2018-11-08

3.  Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.

Authors:  Shinta Mizuno; Tatsuhiro Masaoka; Makoto Naganuma; Taishiro Kishimoto; Momoko Kitazawa; Shunya Kurokawa; Moeko Nakashima; Kozue Takeshita; Wataru Suda; Masaru Mimura; Masahira Hattori; Takanori Kanai
Journal:  Digestion       Date:  2017-06-21       Impact factor: 3.216

Review 4.  Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions.

Authors:  Michael Camilleri; Ibironke Oduyebo; Houssam Halawi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-08       Impact factor: 4.052

Review 5.  Irritable bowel syndrome: a gut microbiota-related disorder?

Authors:  Yogesh Bhattarai; David A Muniz Pedrogo; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-11-23       Impact factor: 4.052

6.  Irritable Bowel Syndrome.

Authors:  Kristen Ronn Weaver; Gail DʼEramo Melkus; Wendy A Henderson
Journal:  Am J Nurs       Date:  2017-06       Impact factor: 2.220

7.  [Irritable bowel syndrome and functional dyspepsia : Diagnosis and treatment].

Authors:  L Gottschalk; V Andresen; P Layer
Journal:  Internist (Berl)       Date:  2022-01-10       Impact factor: 0.743

8.  Functional Abdominal Cramping Pain: Expert Practical Guidance.

Authors:  Stefan Müller-Lissner; Viola Andresen; Maura Corsetti; Luis Bustos Fernández; Sylvie Forestier; Fabio Pace; Miguel A Valdovinos
Journal:  J Clin Gastroenterol       Date:  2022-09-23       Impact factor: 3.174

9.  The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database.

Authors:  Gyu Lee Kim; Yu Hyeon Yi; Hye Rim Hwang; Jinmi Kim; Youngmin Park; Yun Jin Kim; Jeong Gyu Lee; Young Jin Tak; Seung Hun Lee; Sang Yeoup Lee; Youn Hye Cho; Eun Ju Park; Youngin Lee
Journal:  J Clin Med       Date:  2021-05-10       Impact factor: 4.241

Review 10.  Treating the Metabolic Syndrome by Fecal Transplantation-Current Status.

Authors:  Stephen D H Malnick; David Fisher; Marina Somin; Manuela G Neuman
Journal:  Biology (Basel)       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.